Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| BINDING AGENT | CD22 binding agent |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Lymphoma, B-Cell | 1 | D016393 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2108357 |
CONTENTS